Swedish Orphan Biovitrum
441.40 SEK
+0.09 %
Less than 1K followers
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.09 %
+7.19 %
+9.69 %
+32.63 %
+32.31 %
+42.39 %
+93.68 %
+212.45 %
+825.01 %
Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
157.76B SEK
Turnover
125.74M SEK
Revenue
28.24B
EBIT %
3.07 %
P/E
317.55
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
16/7
2026
Interim report Q2'26
27/10
2026
Interim report Q3'26
4/2
2027
Annual report '26
All
Press releases
ShowingAll content types
Swedish Orphan Biovitrum AB: Positiva topline-resultat från den pivotala fas 3-studien REDUCE 2 med pozdeutinurad vid gikt
Swedish Orphan Biovitrum AB: Bulletin from Sobi's Annual General Meeting (AGM)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools